MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Scales"

  • 2025 International Congress

    Integrating Counterclockwise Theory, Mental Imagery, and Art Therapy for Parkinson’s Disease: A Proposed Protocol for Motor and Non-motor Symptom Management

    WJ. Hur, HR. Yoo, MS. Park, JW. Seo, JY. Hur (Daejeon, Republic of Korea)

    Objective: This review/protocol proposal explores whether combining three concepts Counterclockwise theory, Imagery training, and Art therapy can improve motor symptoms and enhance the quality of…
  • 2025 International Congress

    A Data Visualization Tool to Improve Interpretation of MDS-UPDRS Results Post-DBS

    C. van Horne, G. Quintero, J. Hixson (Lexington, USA)

    Objective: To evaluate the potential of our previously developed data visualization platform for the Movement Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) as a…
  • 2025 International Congress

    Lived Experiences in early clinical PD: Developing a Framework of a Novel Patient-reported Outcome (PRO) Fit-for-purpose for Disease Modification Therapeutic Trials

    T. Mestre, J. Ding, N. Lapelle, G. Stebbins (Chicago, USA)

    Objective: To characterize the lived experience of individuals at a prodromal stage of PD or with a recent clinical diagnosis. Background: There is no validated…
  • 2025 International Congress

    Archimedes spiral based non-linear regression machine learning model for predicting tremor’s severity

    A. Rekik, S. Laatoui, M. Abid, R. Guizani, I. Rekik, S. Ben Amor (Sousse, Tunisia)

    Objective: To predict tremor severity using the Archimedes spiral drawing, a commonly used item in tremor assessment scales. Background: The Archimedes spiral is widely used…
  • 2025 International Congress

    Eye movement abnormalities in GBA1-related Parkinson’s disease and non-manifesting GBA1-carriers

    G. Riboldi, T. Hudson, H. Conn, K. Astudillo, J. Rizzo, S. Frucht, J. Rucker (New York, USA)

    Objective: To perform an in-depth characterization of eye movement abnormalities in Parkinson’s disease (PD) and non-manifesting carriers of GBA1 pathogenic variants. Background: Eye movement abnormalities…
  • 2025 International Congress

    Development of a Rating Instrument to Identify Catatonia by Virtual Viewing of Motor Assessments

    N. Kadubandi, A. Elshourbagy, L. Smith, A. Balousha, P. Tacik, J. Barnett, J. Brasic (Baltimore, USA)

    Objective: To develop a rating instrument to identify catatonia by virtual viewing of motor assessments Background: Catatonia is a motor comorbidity complicating mental and physical…
  • 2025 International Congress

    Can Wearable Inertial Sensors Accurately Reflect Parkinson’s Disease Severity? A Systematic Review and Meta-Analysis

    H. Youssef, M. Sabıroğlu, S. Abdelrahman, T. Hasanin, M. Manay, M. Gönül, S. Del Din, A. Vural (Istanbul, Turkey)

    Objective: To evaluate the ability of inertial measurement units (IMUs) in detecting the severity of motor symptoms in Parkinson’s disease (PD) by examining the relationship…
  • 2025 International Congress

    Development of the Lewy Body Dementia Domain Rating Scale (LBD-DRS): A disease-specific outcome measure

    E. Matar, B. Boeve, J. Kane, F. Rodriguez-Porcel, A. Schrag, S. Sikkes, J. Taylor (New South Wales, Australia)

    Objective: To develop and refine the Lewy Body Dementia Domain Rating Scale (LBD-DRS) as a disease-specific outcome measure tailored to the unique clinical features of…
  • 2025 International Congress

    Comparison of 3 Tests for Subjective Cognitive Complaints in Early Parkinson’s Disease

    R. Hoe, S. Ng, R. Chen, X. Choi, D. Heng, S. Neo, K. Tay, W. Au, E. Tan, L. Tan, Z. Xu (Singapore, Singapore)

    Objective: ​​​​​To compare 3 scales which have been used in literature to determine subjective cognitive complaints (SCC) in Parkinson’s disease (PD) and explore their relationship…
  • 2025 International Congress

    Disease Monitoring through the PKAN Disease Rating Scale (PKAN-DRS) in Pantothenate Kinase-Associated Neurodegeneration (PKAN)

    A. Salazar-Villacorta, R. Spaull, M. Correa-Vela, A. Cazurro, J. Ferrero Turión, A. Soo, M. González, A. Macaya, B. Pérez-Dueñas, M. Kurian (London, United Kingdom)

    Objective: To assess the utility of PKAN-DRS as an outcome measure for monitoring disease progression in PKAN . Background: The PKAN-DRS assess multiple domains affected…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 39
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley